Paradoxical Pro-invasive Effect of the Serine Proteinase Inhibitor Tissue Factor Pathway Inhibitor-2 on Human Hepatocellular Carcinoma Cells
Open Access
- 10 November 2000
- journal article
- Published by Elsevier
- Vol. 275 (45), 35565-35569
- https://doi.org/10.1074/jbc.m006101200
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitorJournal of Clinical Investigation, 1999
- Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: Evidence for a role of hepatocyte growth factorHepatology, 1997
- Extracellular Matrix-Associated Serine Protease Inhibitors (Mr33,000, 31,000, and 27,000) Are Single-Gene Products with Differential Glycosylation: cDNA Cloning of the 33-kDa Inhibitor Reveals Its Identity to Tissue Factor Pathway Inhibitor-2Archives of Biochemistry and Biophysics, 1996
- Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?The Journal of cell biology, 1996
- Alpha-smooth muscle actin-positive stromal cells in cholangiocarcinomas, hepatocellular carcinomas and metastatic liver carcinomasJournal of Hepatology, 1996
- Inhibitory Properties of a Novel Human Kunitz-Type Protease Inhibitor Homologous to Tissue Factor Pathway InhibitorBiochemistry, 1996
- Human myofibroblastlike cells obtained by outgrowth are representative of the fibrogenic cells in the liverHepatology, 1995
- Novel Extracellular Matrix-Associated Serine Proteinase Inhibitors from Human Skin FibroblastsArchives of Biochemistry and Biophysics, 1995
- Mitogenic effect of transforming growth factor-β1 on human ito cells in culture: Evidence for mediation by endogenous platelet-derived growth factorHepatology, 1993
- Hepatocellular Carcinoma: Recent ProgressHepatology, 1992